HANSOH PHARMAC. HD-00001 (3KY) — Working Capital to Net Assets Ratio
HANSOH PHARMAC. HD-00001 (3KY) has a Working Capital to Net Assets ratio of 88.1% as of December 2025. Working capital of €31.16 Billion (current assets of €35.56 Billion minus current liabilities of €4.39 Billion) is measured against net assets of €35.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see HANSOH PHARMAC. HD-00001 assets under control.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
HANSOH PHARMAC. HD-00001 Working Capital to Net Assets (2021–2025)
This chart shows how HANSOH PHARMAC. HD-00001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 88.1%, reflecting working capital of €31.16 Billion against net assets of €35.36 Billion EUR. Explore HANSOH PHARMAC. HD-00001 (3KY) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for HANSOH PHARMAC. HD-00001 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read HANSOH PHARMAC. HD-00001 (3KY) total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.1% | €31.16 Billion | €35.36 Billion | €35.56 Billion | €4.39 Billion | ▲ +1.8 pp |
| 2024 | 86.3% | €24.75 Billion | €28.68 Billion | €27.44 Billion | €2.70 Billion | ▲ +0.9 pp |
| 2023 | 85.4% | €22.02 Billion | €25.79 Billion | €28.88 Billion | €6.86 Billion | ▼ -17.1 pp |
| 2022 | 102.5% | €23.21 Billion | €22.65 Billion | €25.83 Billion | €2.62 Billion | ▲ +1.9 pp |
| 2021 | 100.6% | €20.16 Billion | €20.03 Billion | €23.18 Billion | €3.02 Billion | — |